FOXO Technologies (NYSE:FOXO – Get Rating) and Primerica (NYSE:PRI – Get Rating) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Profitability

This table compares FOXO Technologies and Primerica's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for FOXO Technologies and Primerica, as reported by MarketBeat.com.

Primerica has a consensus price target of $202.75, suggesting a potential upside of 11.09%. Given Primerica's higher possible upside, analysts clearly believe Primerica is more favorable than FOXO Technologies.

Earnings & Valuation

This table compares FOXO Technologies and Primerica's gross revenue, earnings per share and valuation.

Primerica has higher revenue and earnings than FOXO Technologies.

Volatility & Risk

FOXO Technologies has a beta of 2.22, suggesting that its share price is 122% more volatile than the S&P 500. Comparatively, Primerica has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500.

Institutional and Insider Ownership

73.9% of FOXO Technologies shares are held by institutional investors. Comparatively, 91.6% of Primerica shares are held by institutional investors. 3.0% of FOXO Technologies shares are held by company insiders. Comparatively, 0.9% of Primerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Primerica beats FOXO Technologies on 9 of the 12 factors compared between the two stocks.

About FOXO Technologies

(Get Rating)

FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.

About Primerica

(Get Rating)

Primerica, Inc. engages in the provision of financial products to middle-income households. It operates through the following segments: Term Life Insurance, Investment and Savings Products, Senior Health, and Corporate and Other Distributed Products. The Term Life Insurance segment includes underwriting profits in the in-force book of term life insurance policies. The Investment and Savings Products segment is involved in managed mutual funds and annuities, and segregated funds. The Senior Health segment consists of the distribution of Medicare-related insurance products underwritten by third-party health insurance carriers to eligible Medicare participants through e-TeleQuote's licensed health insurance agents. The Corporate and Other Distributed Products segment consists of revenues and expenses related to discontinued lines of insurance. The company was founded by Arthur L. Williams, Jr. and Angela Williams on February 10, 1977, and is headquartered in Duluth, GA.

Receive News & Ratings for FOXO Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FOXO Technologies and related companies with MarketBeat.com's FREE daily email newsletter.